Lipolytech
Digestive enzymes and in vitro digestion services for nutrition and pharmaceutical researchers
Highlights
- New on EvolcAdded 2026-11-13
About Lipolytech
Lipolytech supplies digestive enzymes for simulating gastric and intestinal phases in in vitro digestion models, with a focus on lipolytic enzymes. It also provides services using a two-step static model with gastric and duodenal phases.
Its products and services support nutrition research on food digestibility and pre-clinical pharmaceutical research on lipid-based formulations and oral drug bioavailability. Lipolytech was founded in 2017 and is based in Marseille, France.
Product: Digestive enzymes and in vitro digestion services using a two-step static model.
Jobs at Lipolytech
Leadership
- Sawsan AMARA · Founder & CEOSource: company website
More biotech & pharma companies
Lipther
Biotechnology research and lipid-based product development for nutrition and therapeutic applicationsNew on EvolcLodiag
Water analysis laboratory identifying emerging micropollutants for environmental and industrial clientsNew on EvolcLymph Tech
Developing mRNA gene therapies for patients with lymphedema and related lymphatic disordersYoung companyNew on EvolcLys Therapeutics
Biotech developing an antibody to treat blood-brain barrier dysfunction and neuroinflammation in neurological diseasesNew on EvolcMaat Pharma
Clinical-stage microbiome medicines developer aiming to improve survival in cancer patients, based in LyonMabqi
Discovers and develops therapeutic antibodies for biopharmaceutical companies and patients
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.